Tony Hebden

417 total citations
27 papers, 295 citations indexed

About

Tony Hebden is a scholar working on Psychiatry and Mental health, Infectious Diseases and Pharmacology. According to data from OpenAlex, Tony Hebden has authored 27 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 9 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in Tony Hebden's work include Schizophrenia research and treatment (11 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (8 papers). Tony Hebden is often cited by papers focused on Schizophrenia research and treatment (11 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (8 papers). Tony Hebden collaborates with scholars based in United States, Germany and Sweden. Tony Hebden's co-authors include Iftekhar Kalsekar, Yonghua Jing, Leslie Citrome, Robert A. Forbes, Ross A. Baker, Zhenchao Guo, Timothy Juday, Susan K. Brenneman, Albert Yeung and Lee Baer and has published in prestigious journals such as Journal of Clinical Oncology, Annals of the Rheumatic Diseases and Psychiatric Services.

In The Last Decade

Tony Hebden

26 papers receiving 287 citations

Peers

Tony Hebden
Dustin J. Rabideau United States
Maria Speed Denmark
Darmendra Ramcharran United States
Nadia Reynolds United States
Christopher A. Kenedi New Zealand
Judy Van Der Wende United States
Sophie Juul Denmark
I. Duchesne Belgium
Drenna Waldrop United States
C. Regini Italy
Dustin J. Rabideau United States
Tony Hebden
Citations per year, relative to Tony Hebden Tony Hebden (= 1×) peers Dustin J. Rabideau

Countries citing papers authored by Tony Hebden

Since Specialization
Citations

This map shows the geographic impact of Tony Hebden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Hebden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Hebden more than expected).

Fields of papers citing papers by Tony Hebden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Hebden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Hebden. The network helps show where Tony Hebden may publish in the future.

Co-authorship network of co-authors of Tony Hebden

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Hebden. A scholar is included among the top collaborators of Tony Hebden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Hebden. Tony Hebden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnston, Stephen S., Timothy Juday, Amanda M. Farr, Bong-Chul Chu, & Tony Hebden. (2014). Comparison between guideline-preferred and nonpreferred first-line HIV antiretroviral therapy.. PubMed. 20(6). 448–55. 3 indexed citations
2.
Citrome, Leslie, Iftekhar Kalsekar, Ross A. Baker, & Tony Hebden. (2014). A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults. Current Medical Research and Opinion. 30(8). 1629–1641. 34 indexed citations
3.
4.
5.
Bonafede, Machaon, et al.. (2013). Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapy. Journal of Medical Economics. 16(4). 552–559. 3 indexed citations
6.
Johnston, Stephen S., Timothy Juday, Derek Espindle, et al.. (2013). Comparative Incidence and Health Care Costs of Medically Attended Adverse Effects among U.S. Medicaid HIV Patients on Atazanavir- or Darunavir-Based Antiretroviral Therapy. Value in Health. 16(2). 418–425. 7 indexed citations
7.
Schneider, G, Timothy Juday, Charles Wentworth, et al.. (2013). Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA. AIDS Care. 25(11). 1470–1476. 10 indexed citations
8.
Citrome, Leslie, Iftekhar Kalsekar, Zhenchao Guo, Kimberly K. Laubmeier, & Tony Hebden. (2013). Diagnoses Associated With Use of Atypical Antipsychotics in a Commercial Health Plan: A Claims Database Analysis. Clinical Therapeutics. 35(12). 1867–1875. 28 indexed citations
9.
Hebden, Tony, et al.. (2013). Health Care Costs Associated With First- And Second-Line Switching Of Biologic Disease-Modifying Antirheumatic Drugs. Value in Health. 16(3). A222–A222. 3 indexed citations
10.
Khanna, Dinesh, Elena Massarotti, Lisa Rosenblatt, et al.. (2013). THU0522 Comparison of Cost- Efficacy of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases. 72. A340–A341. 1 indexed citations
11.
Chang, Trina, Yonghua Jing, Albert Yeung, et al.. (2012). Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial. General Hospital Psychiatry. 34(2). 105–112. 24 indexed citations
12.
13.
Jing, Yonghua, Zhenchao Guo, Iftekhar Kalsekar, et al.. (2012). Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006–2010). International Clinical Psychopharmacology. 28(2). 87–90. 9 indexed citations
14.
15.
Taneja, Charu, et al.. (2012). Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens. Expert Opinion on Pharmacotherapy. 13(15). 2111–2118. 6 indexed citations
16.
Han, Steven‐Huy B., Edward Mena, Michael Li, et al.. (2012). Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy. Journal of Medical Economics. 15(6). 1159–1166. 12 indexed citations
17.
Broder, Michael S., John A. Bates, Yonghua Jing, et al.. (2011). Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia. Journal of Medical Economics. 15(1). 105–111. 10 indexed citations
18.
Jing, Yonghua, Iftekhar Kalsekar, Suellen M. Curkendall, et al.. (2011). Intent-to-Treat Analysis of Health Care Expenditures of Patients Treated With Atypical Antipsychotics as Adjunctive Therapy in Depression. Clinical Therapeutics. 33(9). 1246–1257. 9 indexed citations
19.
Jing, Yonghua, Stephen S. Johnston, Robert Fowler, et al.. (2011). Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder. Journal of Medical Economics. 14(6). 777–786. 6 indexed citations
20.
Guo, Zhenchao, Gilbert L’Italien, Yonghua Jing, et al.. (2011). A real-world data analysis of dose effect of second-generation antipsychotic therapy on hemoglobin A1C level. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(5). 1326–1332. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dustin J. Rabideau Breakdown of academic impact, for papers by Maria Speed Breakdown of academic impact, for papers by Darmendra Ramcharran Breakdown of academic impact, for papers by Nadia Reynolds Breakdown of academic impact, for papers by Christopher A. Kenedi Breakdown of academic impact, for papers by Judy Van Der Wende Breakdown of academic impact, for papers by Sophie Juul Breakdown of academic impact, for papers by I. Duchesne Breakdown of academic impact, for papers by Drenna Waldrop Breakdown of academic impact, for papers by C. Regini
Rankless by CCL
2026